Hospital and Nursing Home Probiotics Market, By Product; By Application; By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa ), Global Trend Analysis, Competitive Landscape & Forecast, 2019-2030

Description

Global Hospital and Nursing Home Probiotics Market Set to Surpass USD 91 Million by 2030

Global Hospital and Nursing Home Probiotics Market is thriving due to a rising awareness about gut health, increasing use of probiotics to prevent infections, growing elderly population, and an increasing demand for personalized healthcare.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Hospital and Nursing Home Probiotics Market size by value at USD 69.00 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Hospital and Nursing Home Probiotics Market size to expand at a CAGR of 4.30% reaching a value of USD 91.10 million by 2030. Global Hospital and Nursing Home Probiotics Market is driven by the growing awareness about probiotics' role in enhancing gut health and immunity, particularly in vulnerable populations such as the elderly and patients with chronic illnesses. The increasing prevalence of gastrointestinal disorders, rising demand for non-invasive treatments, and the growing adoption of probiotics for infection prevention and recovery support in healthcare settings also fuel market growth. Additionally, advancements in probiotic formulations and increased healthcare expenditures further boost demand in hospitals and nursing homes.

Opportunity - Growing Preference for Personalized Medicine

Rising trend of personalized medicine is a significant growth driver for Global Hospital and Nursing Home Probiotics Market. With increasing awareness of individual microbiome variations, healthcare providers are turning to tailored probiotic treatments to address specific health conditions. This approach ensures better patient outcomes, particularly for digestive, immune, and mental health issues. Personalized probiotic formulations, backed by advancements in microbiome research and genomic analysis, are fueling demand in hospitals and nursing homes, promoting market expansion.

Impact of Escalating Geopolitical Tensions on Global Hospital and Nursing Home Probiotics Market

Escalating geopolitical tensions could impact Global Hospital and Nursing Home Probiotics Market by causing supply chain disruptions, trade restrictions, and increased tariffs, particularly affecting raw material sourcing and distribution. It may lead to higher costs, delays, and uncertainty in manufacturing and logistics. Additionally, market access could be limited due to political instability in key regions, affecting product availability and pricing. Healthcare budgets may also be strained, potentially reducing demand for probiotics in hospital and nursing home settings.

Gut Health Segment Leads the Market by Application

The gut health segment holds the largest share of Global Hospital and Nursing Home Probiotics Market by application, due to the increasing awareness of digestive health and the benefits of probiotics in maintaining a healthy gut microbiome. Probiotics are widely used to prevent and treat gastrointestinal disorders, which are common in hospital and nursing home settings. The demand for gut health probiotics is driven by their effectiveness in improving digestion and overall health outcomes.

Competitive Landscape

Global Hospital and Nursing Home Probiotics Market is fiercely competitive, with numerous companies vying for a larger market share. Major companies in the market include Bio-K Plus International, American Lifeline, Rising Pharmaceuticals, Becton Dickinson and Company, NutraScience Labs, Vitakem Nutraceuticals, Probium, Protexin, Nutraceutix, Nebraska Cultures, Mercola, Eva Nutra, and UP4 Probiotics. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Global Hospital and Nursing Home Probiotics Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Hospital and Nursing Home Probiotics Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technological trends in Global Hospital and Nursing Home Probiotics Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC24802

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Hospital and Nursing Home Probiotics Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Growing awareness of probiotics
  - 3.2.1.2. Increasing healthcare expenditure
  - 3.2.1.3. Rising prevalence of chronic diseases
- 3.2.2. Restraints
  - 3.2.2.1. Lack of standardization in the probiotic market
  - 3.2.2.2. Regulatory challenges associated with probiotics
  - 3.2.2.3. High costs of probiotic products
- 3.2.3. Opportunities
  - 3.2.3.1. Growing trend of personalized medicine
  - 3.2.3.2. Expanding applications of probiotics
  - 3.2.3.3. Developing countries with growing healthcare needs
- 3.2.4. Challenges
  - 3.2.4.1. Ensuring the quality and consistency of probiotic strains
  - 3.2.4.2. Competition from generic products
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry

4. Global Hospital and Nursing Home Probiotics Market: Marketing Strategies

5. Global Hospital and Nursing Home Probiotics Market: Pricing Analysis

6. Global Hospital and Nursing Home Probiotics Market: Geography Analysis

6.1. Global Hospital and Nursing Home Probiotics Market, Geographical Analysis, 2023
6.2. Global Hospital and Nursing Home Probiotics, Market Attractiveness Analysis, 2024-2030

7. Global Hospital and Nursing Home Probiotics Market Overview

7.1. Market Size & Forecast, 2019-2030
- 7.1.1. By Value (USD Million)
7.2. Market Share and Forecast
- 7.2.1. By Product
  - 7.2.1.1. Lactobacillus
  - 7.2.1.2. Bifidobacterium
  - 7.2.1.3. Gram-positive Cocci
  - 7.2.1.4. Others
- 7.2.2. By Application
  - 7.2.2.1. Gut Health
  - 7.2.2.2. Immunity
  - 7.2.2.3. Wellness
  - 7.2.2.4. Others
- 7.2.3. By Region
  - 7.2.3.1. North America
  - 7.2.3.2. Europe
  - 7.2.3.3. Asia Pacific (APAC)
  - 7.2.3.4. Latin America (LATAM)
  - 7.2.3.5. Middle East and Africa (MEA)

8. North America Hospital and Nursing Home Probiotics Market

8.1. Market Size & Forecast, 2019-2030
- 8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Application
- 8.2.3. By Country
  - 8.2.3.1. United States
  - 8.2.3.1.1. By Product
  - 8.2.3.1.2. By Application
  - 8.2.3.2. Canada
  - 8.2.3.2.1. By Product
  - 8.2.3.2.2. By Application

9. Europe Hospital and Nursing Home Probiotics Market

9.1. Market Size & Forecast, 2019-2030
- 9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Application
- 9.2.3. By Country
  - 9.2.3.1. Germany
  - 9.2.3.1.1. By Product
  - 9.2.3.1.2. By Application
  - 9.2.3.2. United Kingdom
  - 9.2.3.2.1. By Product
  - 9.2.3.2.2. By Application
  - 9.2.3.3. Italy
  - 9.2.3.3.1. By Product
  - 9.2.3.3.2. By Application
  - 9.2.3.4. France
  - 9.2.3.4.1. By Product
  - 9.2.3.4.2. By Application
  - 9.2.3.5. Spain
  - 9.2.3.5.1. By Product
  - 9.2.3.5.2. By Application
  - 9.2.3.6. Belgium
  - 9.2.3.6.1. By Product
  - 9.2.3.6.2. By Application
  - 9.2.3.7. Russia
  - 9.2.3.7.1. By Product
  - 9.2.3.7.2. By Application
  - 9.2.3.8. The Netherlands
  - 9.2.3.8.1. By Product
  - 9.2.3.8.2. By Application
  - 9.2.3.9. Rest of Europe
  - 9.2.3.9.1. By Product
  - 9.2.3.9.2. By Application

10. Asia Pacific Hospital and Nursing Home Probiotics Market

10.1. Market Size & Forecast, 2019-2030
- 10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Application
- 10.2.3. By Country
  - 10.2.3.1. China
  - 10.2.3.1.1. By Product
  - 10.2.3.1.2. By Application
  - 10.2.3.2. India
  - 10.2.3.2.1. By Product
  - 10.2.3.2.2. By Application
  - 10.2.3.3. Japan
  - 10.2.3.3.1. By Product
  - 10.2.3.3.2. By Application
  - 10.2.3.4. South Korea
  - 10.2.3.4.1. By Product
  - 10.2.3.4.2. By Application
  - 10.2.3.5. Australia & New Zealand
  - 10.2.3.5.1. By Product
  - 10.2.3.5.2. By Application
  - 10.2.3.6. Indonesia
  - 10.2.3.6.1. By Product
  - 10.2.3.6.2. By Application
  - 10.2.3.7. Malaysia
  - 10.2.3.7.1. By Product
  - 10.2.3.7.2. By Application
  - 10.2.3.8. Singapore
  - 10.2.3.8.1. By Product
  - 10.2.3.8.2. By Application
  - 10.2.3.9. Vietnam
  - 10.2.3.9.1. By Product
  - 10.2.3.9.2. By Application
  - 10.2.3.10. Rest of APAC
  - 10.2.3.10.1. By Product
  - 10.2.3.10.2. By Application

11. Latin America Hospital and Nursing Home Probiotics Market

11.1. Market Size & Forecast, 2019-2030
- 11.1.1. By Value (USD Million)
11.2. Market Share & Forecast
- 11.2.1. By Product
- 11.2.2. By Application
- 11.2.3. By Country
  - 11.2.3.1. Brazil
  - 11.2.3.1.1. By Product
  - 11.2.3.1.2. By Application
  - 11.2.3.2. Mexico
  - 11.2.3.2.1. By Product
  - 11.2.3.2.2. By Application
  - 11.2.3.3. Argentina
  - 11.2.3.3.1. By Product
  - 11.2.3.3.2. By Application
  - 11.2.3.4. Peru
  - 11.2.3.4.1. By Product
  - 11.2.3.4.2. By Application
  - 11.2.3.5. Rest of LATAM
  - 11.2.3.5.1. By Product
  - 11.2.3.5.2. By Application

12. Middle East & Africa Hospital and Nursing Home Probiotics Market

12.1. Market Size & Forecast, 2019-2030
- 12.1.1. By Value (USD Million)
12.2. Market Share & Forecast
- 12.2.1. By Product
- 12.2.2. By Application
- 12.2.3. By Country
  - 12.2.3.1. Saudi Arabia
  - 12.2.3.1.1. By Product
  - 12.2.3.1.2. By Application
  - 12.2.3.2. UAE
  - 12.2.3.2.1. By Product
  - 12.2.3.2.2. By Application
  - 12.2.3.3. Qatar
  - 12.2.3.3.1. By Product
  - 12.2.3.3.2. By Application
  - 12.2.3.4. Kuwait
  - 12.2.3.4.1. By Product
  - 12.2.3.4.2. By Application
  - 12.2.3.5. South Africa
  - 12.2.3.5.1. By Product
  - 12.2.3.5.2. By Application
  - 12.2.3.6. Nigeria
  - 12.2.3.6.1. By Product
  - 12.2.3.6.2. By Application
  - 12.2.3.7. Algeria
  - 12.2.3.7.1. By Product
  - 12.2.3.7.2. By Application
  - 12.2.3.8. Rest of MEA
  - 12.2.3.8.1. By Product
  - 12.2.3.8.2. By Application

13. Competitive Landscape

13.1. List of Key Players and Their Offerings
13.2. Global Hospital and Nursing Home Probiotics Market Share Analysis, 2023
13.3. Competitive Benchmarking, By Operating Parameters
13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

14. Impact of Escalating Geopolitical Tensions on Global Hospital and Nursing Home Probiotics Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

15.1. Bio - K Plus International
15.2. American Lifeline
15.3. Rising Pharmaceuticals
15.4. Becton Dickinson and Company
15.5. NutraScience Labs
15.6. Vitakem Nutraceuticals
15.7. Probium
15.8. Protexin
15.9. Nutraceutix
15.10. Nebraska Cultures
15.11. Mercola
15.12. Eva Nutra
15.13. UP4 Probiotics
15.14. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

17.1. Qualitative Research
- 17.1.1. Primary & Secondary Research
17.2. Quantitative Research
17.3. Market Breakdown & Data Triangulation
- 17.3.1. Secondary Research
- 17.3.2. Primary Research
17.4. Breakdown of Primary Research Respondents, By Region
17.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable